CD24 and breast carcinoma: Studying CRCs in breast carcinoma, Al-Hajj et al. suggested that CD44+CD24– identified cells with preserved potency and tumor initiating ability while CD24 expression marks epithelial- to- mesenchymal transition (EMT) [17].